ConductScience.org, home

Paper11186331

Molecular mechanisms of tumor-bone interactions in osteolytic metastases.

Chirgwin JM and 1 other. Crit Rev Eukaryot Gene Expr, 2000. Cited by 165 papers, by iCite.

Cite this record

ConductScience Library. Molecular mechanisms of tumor-bone interactions in osteolytic metastases. Papers, record 11186331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11186331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
PubMed
Journal
Crit Rev Eukaryot Gene Expr
PubMed
Year
2000
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
165
iCite
Relative citation ratio, by iCite
3.52
iCite
Revised in PubMed
2018-11-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chirgwin JMJ M
2Guise TAT A

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone NeoplasmsMajor topic
Bone and Bones
Breast Neoplasms
Calcium
Gonadal Steroid Hormones
Humans
Lymphocytes
Neovascularization, Pathologic
Osteoclasts
Osteolysis
Parathyroid Hormone-Related Protein
Proteins
Transforming Growth Factor beta

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA40035NCI NIH HHSUnited StatesP01CA040035PubMed and NIHNIH RePORTER
CA69158NCI NIH HHSUnited StatesR01CA069158PubMed and NIHNIH RePORTER
R29CA069158NIHNIH RePORTER

Download CSV of grants

Cited by71

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 165 citations.

PMIDTitleJournalYearIn PapersSource
42775174Tumor-nerve crosstalk: peripheral mechanisms mediating bone tumor progression and cancer-induced bone pain.Front Oncol2026https://conductscience.org/library/papers/42775174PubMed
41596432Bone Metastasis in Estrogen Receptor-Positive Breast Cancer: Molecular Insights and Therapeutic Advances.Int J Mol Sci2026https://conductscience.org/library/papers/41596432PubMed
41249489Pharmacological inhibition of myostatin effectively ameliorates osteolytic lesions in syngeneic and xenograft breast cancer mouse models.Oncogene2025https://conductscience.org/library/papers/41249489PubMed
38427117
The novel cytotoxic polybisphosphonate osteodex decreases bone resorption by enhancing cell death of mature osteoclasts without affecting osteoclastogenesis of RANKL-stimulated mouse bone marrow macrophages.
Invest New Drugs2024https://conductscience.org/library/papers/38427117PubMed
38148788Pain associated with breast cancer: etiologies and therapies.Front Pain Res (Lausanne)2023https://conductscience.org/library/papers/38148788PubMed
35685372Deregulated molecules and pathways in the predisposition and dissemination of breast cancer cells to bone.Comput Struct Biotechnol J2022https://conductscience.org/library/papers/35685372PubMed
35355564Identification of MAGEC2/CT10 as a High Calcium-Inducible Gene in Triple-Negative Breast Cancer.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/35355564PubMed
34831167Mechanisms, Diagnosis and Treatment of Bone Metastases.Cells2021https://conductscience.org/library/papers/34831167PubMed
34830748Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells.Cancers (Basel)2021https://conductscience.org/library/papers/34830748PubMed
34268641The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies.Med Oncol2021https://conductscience.org/library/papers/34268641PubMed
32117996RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies.Front Cell Dev Biol2020https://conductscience.org/library/papers/32117996PubMed
30151009PTH1R-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases.Int J Endocrinol2018https://conductscience.org/library/papers/30151009PubMed
29747461Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases.Cancers (Basel)2018https://conductscience.org/library/papers/29747461PubMed
29644008Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma.Oncotarget2018https://conductscience.org/library/papers/29644008PubMed
29088893Clinical study of 99mTc-3P-RGD2 peptide imaging in osteolytic bone metastasis.Oncotarget2017https://conductscience.org/library/papers/29088893PubMed
28799237Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.Cancer Med2017https://conductscience.org/library/papers/28799237PubMed
28764683Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients.BMC Cancer2017https://conductscience.org/library/papers/28764683PubMed
28504970Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.Oncotarget2017https://conductscience.org/library/papers/28504970PubMed
28078478Hypercalcaemia and hypocalcaemia: finding the balance.Support Care Cancer2017https://conductscience.org/library/papers/28078478PubMed
28071724Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.Sci Rep2017https://conductscience.org/library/papers/28071724PubMed

See all 71 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PTHLH5744PubTator's text mininghttps://conductscience.org/library/genes/5744NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11186331

GET https://conductscience.org/api/papers/v1/11186331/cited_by?page=2